Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
22.39
+0.17 (0.77%)
At close: Sep 26, 2025, 4:00 PM EDT
22.37
-0.02 (-0.09%)
After-hours: Sep 26, 2025, 4:43 PM EDT
Apellis Pharmaceuticals Employees
As of December 31, 2024, Apellis Pharmaceuticals had 710 total employees, including 705 full-time and 5 part-time employees. The number of employees increased by 4 or 0.57% compared to the previous year.
Employees
710
Change (1Y)
4
Growth (1Y)
0.57%
Revenue / Employee
$1,062,886
Profits / Employee
-$321,372
Market Cap
2.83B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
APLS News
- 18 days ago - Apellis Pharmaceuticals, Inc. (APLS) Presents At Baird Global Healthcare Conference (Transcript) - Seeking Alpha
- 23 days ago - Apellis Pharmaceuticals, Inc. (APLS) Presents At Cantor Global Healthcare Conference 2025 (Transcript) - Seeking Alpha
- 24 days ago - Apellis Pharmaceuticals, Inc. (APLS) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Apellis Pharmaceuticals: Restart Of Growth Story After Empaveli's New Approval - Seeking Alpha
- 2 months ago - Apellis Pharmaceuticals, Inc. (APLS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Apellis Pharmaceuticals: The Picture Becomes Clearer - Seeking Alpha
- 2 months ago - Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results - GlobeNewsWire